The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial.

Authors :: Sivalingam S
Hein Zobel E
Hansen CS
Ripa RS
von Scholten BJ
Rotbain Curovic V
Kjaer A
Jensen JK
Hansen TW
Rossing P
Source :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Aug; Vol. 24 (8), pp. 1638-1642. Date of Electronic Publication: 2022 May 12.
Publication Year :: 2022

Subjects :: Double-Blind Method
Humans
Hypoglycemic Agents pharmacology
Hypoglycemic Agents therapeutic use
Stroke Volume
Treatment Outcome
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy
Liraglutide pharmacology
Liraglutide therapeutic use

Full Text Access

Tools